Dye laser photocoagulation of macular subretinal neovascularization in pathological myopia. A randomized study of three different wavelengths.
The authors present a randomized study of 27 eyes affected by pathological myopia with macular subretinal neovascularization which were treated with a tunable dye laser. The effectiveness of three different wavelengths (577, 590 and 620 nm) in the direct treatment of subretinal neovascularizations was evaluated in 3 groups of 9 patients each. Statistical analysis of both visual and anatomical results did not show significant differences among the three wavelengths used.
Brancato
R
R
Department of Ophthalmology, University of Milan, Italy.
Menchini
U
U
Pece
A
A
Capoferri
C
C
Avanza
P
P
Radrizzani
E
E
D000328:Adult; D000368:Aged; D004396:Coloring Agents; D005069:Evaluation Studies as Topic; D005260:Female; D005451:Fluorescein Angiography; D006801:Humans; D053685:Laser Therapy; D008028:Light Coagulation; D008266:Macula Lutea / Q000098:blood supply* / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009216:Myopia / Q000150:complications* / Q000503:physiopathology; D009389:Neovascularization, Pathologic / Q000150:complications / Q000503:physiopathology / Q000601:surgery*; D012008:Recurrence; D014792:Visual Acuity
D004396:Coloring Agents